Search Login Register
Risperidone
(Risperdal Consta)
Summary
Description:
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
Also Known As:
Risperdal Consta; Risperidal; R-64,766; R-64766; Consta, Risperdal Show All >>
Networked: 3594
relevant articles (534 outcomes,
1102 trials/studies)
for this Drug
Key Diseases for which Risperidone is
Relevant
-
Schizophrenia (Dementia Praecox)
:
244 outcomes 621 studies in 1642 results
-
Bipolar Disorder (Mania)
:
63 outcomes 99 studies in 252 results
-
Psychotic Disorders (Schizoaffective Disorder)
:
33 outcomes 116 studies in 321 results
-
Dementia (Dementias)
:
33 outcomes 56 studies in 161 results
-
Autistic Disorder (Autism)
:
27 outcomes 45 studies in 127 results
Show All >>
Drugs Related to Risperidone
-
olanzapine (Zyprexa)
-
Antipsychotic Agents (Antipsychotics)
-
Haloperidol (Haldol)
-
quetiapine (Seroquel)
-
aripiprazole (Abilify)
-
Clozapine (Clozaril)
-
ziprasidone (Geodon)
-
Valproic Acid (Valproate, Semisodium)
-
Lithium
-
Serotonin (5 Hydroxytryptamine)
Show All >>
Therapies Related to Risperidone
-
Injections
-
Drug Therapy (Chemotherapy)
-
Microspheres (Microsphere)
-
Aftercare (After-Treatment)
-
Patient Readmission
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.